- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | FDA Experts Weigh In On Incannex's CannQuit-O With Feedback On CBD As Treatment For Opioid Use Disorder | 1 | Benzinga.com | ||
| Di | Incannex Healthcare Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Di | Incannex Healthcare: Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder | 98 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex or the Company), a leading cannabinoid and psychedelic medicine biotechnology... ► Artikel lesen | |
| 16.04. | Incannex Healthcare Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 04.04. | Incannex prepares IND submission for psychotherapy asset | 3 | Pharmaceutical Technology | ||
| 05.03. | Incannex Healthcare appoints new CFO and Secretary | 3 | Investing.com | ||
| 29.02. | Ampio Pharmaceuticals, Ironwood, Incannex among healthcare movers | 2 | Seeking Alpha | ||
| 28.02. | Incannex says psilocybin therapy lowered anxiety in small study | 5 | BioPharma Dive | ||
| 28.02. | US STOCKS Permian Resources, Vivani, Incannex | 4 | Reuters | ||
| 28.02. | Incannex surges as anxiety disorder drug succeeds in mid-stage study | 2 | Reuters | ||
| 28.02. | Incannex stock surges as anxiety disorder study meets primary goal | 3 | Seeking Alpha | ||
| 28.02. | Psilocybin shows promise in anxiety disorder trial, Incannex reports | 2 | Investing.com | ||
| 28.02. | Incannex Healthcare Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 16.02. | Incannex advances smoking cessation gum in FDA meeting | 1 | Investing.com | ||
| 16.02. | Incannex Healthcare Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.02. | Incannex Healthcare: Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation | 479 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex or the Company), a leading cannabinoid and psychedelic medicine biotechnology... ► Artikel lesen | |
| 14.02. | Incannex Healthcare Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 01.02. | Incannex Healthcare: Clarion Clinics Open for Psychedelic-Assisted Treatments | 1 | GlobeNewswire (USA) | ||
| 01.02. | Incannex Healthcare Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 24.01. | Incannex Healthcare Inc. - 8-K, Current Report | 1 | SEC Filings |
Seite:
1 2 3 Weiter >>
52 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 28,670 | +2,28 % | Fresenius-Beteiligung FMC bestätigt Prognose | BAD HOMBURG (dpa-AFX) - Der Dialysespezialist Fresenius Medical Care (FMC) hat im ersten Quartal von seinem Konzernumbau und den damit zusammenhängenden Sparmaßnahmen profitiert. Das um Sondereffekte... ► Artikel lesen | |
| PROGYNY | 27,530 | -15,29 % | Pre-market Movers: Novavax, MacroGenics, AEye, Sensus Healthcare, Progyny | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.10 A.M. ET).In the Green Novavax, Inc. (NVAX) is up over 108% at $9.30.
AEye... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 52,58 | +0,19 % | Siemens Healthineers: Restrukturierung bei Labordiagnostik trägt Früchte | ERLANGEN (dpa-AFX) - Der Medizintechnikkonzern Siemens Healthineers hat seine Ergebnisse im zweiten Geschäftsquartal verbessert. Dabei trug das Restrukturierungsprogramm im Diagnostikgeschäft Früchte... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,400 | +4,18 % | Fresenius Medical Care mit SONDERMELDUNG: Könnte der Kurs JETZT komplett drehen - Anleger müssen SOFORT reagieren! | ||
| GERRESHEIMER | 100,40 | +1,26 % | BARCLAYS stuft GERRESHEIMER AG auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Gerresheimer mit einem Kursziel von 125 Euro auf "Overweight" belassen. Lagerbestandsabbau der Kunden bleibe... ► Artikel lesen | |
| RXSIGHT | 59,31 | -3,44 % | Why RxSight (RXST) Shares Are Falling | ||
| CARL ZEISS MEDITEC | 94,55 | +0,64 % | Carl Zeiss Meditec: Die Bilanz und das Ringen um die 200-Tage-Linie | Mitte März endete die umfassende Erholung der Carl Zeiss Meditec-Aktie, seit Mitte April ringt sie um die wichtige 200-Tage-Linie. Die morgen erwarteten Ergebnisse des abgelaufenen Quartals dürften... ► Artikel lesen | |
| UNITEDHEALTH | 476,00 | -0,01 % | Smart Money Is Betting Big In UNH Options | ||
| PROCEPT BIOROBOTICS | 62,65 | -0,56 % | Unveiling 4 Analyst Insights On PROCEPT BioRobotics | ||
| PRIVIA HEALTH GROUP | 17,970 | -0,33 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2024 Financial Results | Practice Collections +7.4% compared to 1Q'23Implemented Providers +17.3% compared to 1Q'23Company Reiterated Full Year 2024 Guidance ARLINGTON, Va., May 09, 2024 (GLOBE NEWSWIRE) -- Privia Health... ► Artikel lesen | |
| ATRICURE | 22,300 | +1,36 % | AtriCure Reports First Quarter 2024 Financial Results | MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... ► Artikel lesen | |
| ADAPTHEALTH | 9,670 | +5,22 % | AdaptHealth Corp. Announces First Quarter 2024 Results | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| TREACE MEDICAL CONCEPTS | 4,380 | -1,13 % | Pre-market Movers: Treace Medical Concepts, DoubleVerify, Neo-Concept International, ZoomInfo Technologies, Innodata | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.50 A.M. ET).In the Green Neo-Concept International Group Holdings Limited... ► Artikel lesen | |
| GOODRX | 6,600 | -4,76 % | GoodRx Reports First Quarter 2024 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading destination for prescription savings in the U.S., has released... ► Artikel lesen | |
| LIFEMD | 9,320 | +0,22 % | Earnings call: LifeMD raises 2024 revenue guidance after solid Q1 |
INCANNEX HEALTHCARE INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -0,39 % bei einem Aktienkurs von 2,540 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
